ANUHPHR
NSEAnuh Pharma Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹78.79
0.23 (0.29%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹790 Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
19.3
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹67+17.6%
52W High₹108.46-27.4%
Current Price
₹78.79
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹63.03
Upper Circuit₹94.55
Reference Price
₹78.79
Investment Checklist
Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹74.81
Double Top on 1D (BREAKOUT CONFIRMED) — target ₹73.15
20/50 Bullish Cross detected 2 day(s) ago
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price below SuperTrend (Responsive Setting (Day Trading/Short-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
46%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition
EMA20
79.02
EMA50
78.67
EMA200
81.37
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows4
Lower Highs5
Lower Lows5
Support & Resistance Levels
Resistance (Above)
₹79.70
₹82.65
₹83.87
₹84.95
₹86.53
Support (Below)
₹77.42
₹74.00
₹72.50
₹69.27
₹67.00
Volume Analysis
TrendDECREASING
Change-51.60%
Unusual VolumeNo
Recent MA Crossovers
20/50 Bullish Cross
2 days ago
BUY
Stop Loss Levels
Fixed Risk
1% Risk₹78.00
3% Risk₹76.43
5% Risk₹74.85
7% Risk (Custom)
₹73.27Technical Levels
1x ATR (Volatility)₹75.80
2x ATR (Swing)₹72.81
3x ATR (Trend)₹69.82
Immediate Support₹77.42
Moving Averages
EMA 50 (Trend)₹78.67
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹198.1 Cr | ₹186.5 Cr | ₹185.9 Cr | ₹197.2 Cr |
| Net Profit | ₹12.5 Cr | ₹8.3 Cr | ₹7.6 Cr | ₹13.5 Cr |
| EPS | — | ₹0.83 | ₹0.76 | ₹1.34 |
| Operating Profit | ₹20.1 Cr | ₹13.7 Cr | ₹12.9 Cr | ₹20.9 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Anuh Pharma Limited | ₹78.79 | -0.29% | 19.3 | ₹790 Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 14 Aug 2025 | Dividend - Rs 1.50 Per Share | DIVIDEND |
| 15 Jul 2025 | Bonus 1:1 | BONUS |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for ANUHPHR
View AllNEWS
positive
Business Standard - Markets 51d ago
Anuh Pharma standalone net profit declines 6.26% in the March 2026 quarter
Sales rise 2.01% to Rs 202.12 crore
ANUHPHRHealthcare
positive
Business Standard - Markets 66d ago
Anuh Pharma up 7% on receiving WHO prequalification for anti-malarial API
The buying on the counter came after the company received World Health Organization (WHO) prequalification approval for Amodiaquine Hydrochloride USP
ANUHPHRMEDANTAHealthcare